Hospital Universitari Sant Joan de Reus

Hospital Universitari Sant Joan de Reus is a Catalan university hospital operated by Grup SAGESSA in Reus, Tarragona, with a pioneering harm reduction and substance use disorders program. In 2020, ICEERS partnered with the hospital to conduct the first-ever Phase II clinical trial of ibogaine for opioid-dependent patients on methadone maintenance, making Sant Joan one of Europe’s most historically significant psychedelic research sites.